spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  transmembrane conductance regulator 

 HSMN NewsFeed - 13 May 2021
SpliSense Secures $28.5 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 23 Jul 2019
Proteostasis Therapeutics Announces Management Changes and Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 May 2019
Proteostasis Therapeutics Appoints Dr. Badrul Chowdhury, Former FDA Director of Pulmonology, Allergy, and Rheumatology, to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Mar 2019
Proteostasis Therapeutics Appoints David Arkowitz to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Feb 2019
Proteostasis Therapeutics Appoints Emmanuel Dulac and Kim Drapkin to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Dec 2018
Proteostasis Therapeutics Announces Global License Agreement with Genentech
Biopharmaceuticals Licensing
 HSMN NewsFeed - 4 Apr 2018
Proteostasis Therapeutics Receives FDA Fast Track Designation for Triple Combination Program in Patients with Cystic Fibrosis
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Feb 2016
Proteostasis Therapeutics Receives FDA Fast Track Designation for PTI-428 in Patients With Cystic Fibrosis
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Oct 2015
Allergan Acquires Rights To Ironwood's CONSTELLA(R) (Linaclotide) From Almirall In More Than 40 Countries
Biopharmaceuticals Gastroenterology Acquisitions
 HSMN NewsFeed - 27 Jun 2014
Vertex Receives European CHMP Positive Opinion for KALYDECO(TM) (ivacaftor) in Eight Non-G551D Gating Mutations
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 1 Jul 2013
Illumina Applies CE Mark to MiSeqDx(TM) Cystic Fibrosis System
Diagnostics Regulatory
 HSMN NewsFeed - 2 Jan 2013
FDA Approves Fulyzaq(TM) (Crofelemer) 125 mg Delayed-Release Tablets for the Symptomatic Relief of Diarrhea in Patients with HIV/AIDS on Anti-Retroviral Therapy (ART)
Biopharmaceuticals FDA HIV/AIDS
 HSMN NewsFeed - 28 Nov 2012
Constella(R) (linaclotide) Approved in Europe for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C) in Adults
Biopharmaceuticals Gastroenterology Regulatory
 HSMN NewsFeed - 25 May 2012
Vertex Receives European CHMP Positive Opinion for KALYDECO(TM) (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 22 Mar 2011
Synergy Pharmaceuticals Appoints Dr. Laura Barrow as Vice President of Clinical Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Sep 2009
PTC Therapeutics Initiates Registration-Directed Phase 3 Trial of Ataluren in Cystic Fibrosis
Biopharmaceuticals
 HSMN NewsFeed - 3 Sep 2009
Luminex Receives 510(K) Clearance for New Cystic Fibrosis Test
Diagnostics FDA
 HSMN NewsFeed - 28 Aug 2009
Eurand Granted FDA Approval for ZENPEP(TM)
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Apr 2007
Luminex Licenses Cystic Fibrosis Gene Patent From John Hopkins University
Diagnostics Licensing
 HSMN NewsFeed - 3 Jan 2007
Third Wave Submits 510(k) to FDA for InPlex(TM) Cystic Fibrosis Molecular Test
Diagnostics
 HSMN NewsFeed - 3 Nov 2006
PTC Therapeutics Announces Positive Phase 2 Results For PTC124 in Cystic Fibrosis
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 7

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 7 additional stories matching:
transmembrane conductance regulator
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.